Why Is MILI Randomised?
The MILI trial is designed to test whether metformin, a drug that treats type II diabetes, can reduce the risk of cancer in people with Li Fraumeni Syndrome (LFS). The truth is that we don’t know if it will or … Read More
Newsletter #6
Newsletter #6 George Pantziarka TP53 Trust – Newsletter A muddy day out We begin this quarter’s newsletter with a big thank you to Katie Cole-Fallon who, along with her team, have raised £347 for charity. The group spent a sunny … Read More